全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Role of Multiparameter Analysis of AgNORs in FNA Smears of Thyroid Swellings in Differentiating Benign and Malignant Lesions

DOI: 10.1155/2012/908106

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background. The aim of this study is to assess the role of multiparameter analysis of silver (Ag)-stained nucleolar organizer regions (AgNORs) technique on aspiration smears of thyroid swellings to distinguish between benign and malignant lesions. Materials and Methods. Aspiration smears from 166 cases of thyroid swellings were examined. Diagnosis was confirmed by histology in 61 cases. AgNOR staining was done on FNA smears according to silver-staining protocol proposed by the International Committee for AgNOR quantification. Multiparameter analysis of AgNORs such as mAgNOR, pAgNOR, and AgNOR size grade was done on 50–100 cells under oil immersion lens. Results. AgNOR parameter of benign and malignant thyroid lesions was compared and was found to be statistically significant. Out of 157 satisfactory AgNOR stained cases, 148 (94.3%) were benign lesions and 9 (5.7%) cases were malignant lesions. In AgNOR analysis, sensitivity was found to be 83.33%, specificity 100%, PPV 100%, NPV 98.21%, and accuracy was 98.36%. Conclusions. AgNOR analysis in the FNA smears is a simple, sensitive, and cost-effective method for differentiating benign from malignant thyroid swellings. 1. Introduction The prevalence of thyroid nodules in the general population is about 5% by palpation and increases to 10–55% with the use of ultrasonography [1]. Thyroid nodules are common in women and in areas of iodine deficiency [2]. Benign thyroid disease is extremely common compared to small proportion of malignant neoplasm [1]. The distinction of the benign and malignant thyroid nodules is fundamental, as malignancy necessitates surgery [3]. To avoid unnecessary thyroid surgery, a thyroid scan, ultrasonography, and fine needle aspiration cytology (FNAC) are used as diagnostic tools to differentiate malignant from a benign lesion [4]. The major pitfall of FNAC is that it cannot differentiate between the follicular adenoma and follicular carcinoma [2]. This is why these are usually described as follicular neoplasm or thyroid follicular diseases [5]. The only diagnostic criteria of follicular neoplasm are the presence of vascular and capsular invasion that can be ascertained histologically [6]. Various attempts have been made to improve the diagnostic accuracy of FNAC, including morphometric study, DNA measurement, immunohistochemical and enzyme techniques for thyroid cancer with varying degree of success. It is well known that the silver staining technique for nucleolar organizer regions (AgNORs) has been successfully applied to a wide variety of neoplastic lesions on pathological

References

[1]  J. K. Young, O. G. Lumapas, and R. Mirasol, “Sonography guided fine-needle aspiration biopsy of thyroid nodules: correlation between cytologic and histopathologic findings,” Phillipine Journal of Internal Medicine, vol. 49, no. 1, pp. 8–14, 2011.
[2]  R. Basharat, M. H. Bukhari, S. Saeed, and T. Hamid, “Comparison of fine needle aspiration cytology and thyroid scan in solitary thyroid nodule,” Pathology Research International, vol. 2011, Article ID 754041, 9 pages, 2011.
[3]  A. Sengupta, R. Pal, S. Kar, F. A. Zaman, S. Sengupta, and S. Pal, “Fine needle aspiration cytology as the primary diagnostic tool in thyroid enlargement,” Journal of Natural Science, Biology and Medicine, vol. 2, no. 1, pp. 113–118, 2011.
[4]  S. Asotra and J. Sharma, “Role of AgNORs in thyroid lesions on fine needle aspiration cytology smears,” Journal of Cytology, vol. 25, no. 1, pp. 18–22, 2008.
[5]  D. Ciobanu, I. D. Cǎruntu, C. Vulpoi, N. Florea, and S. E. Giu?cǎ, “Morphometric parameters and silver stain used in diagnosis of thyroid follicular diseases,” Romanian Journal of Morphology and Embryology, vol. 47, no. 4, pp. 323–330, 2006.
[6]  A. Augustynowicz, J. Dziecio?, M. Barwijuk-Macha?a, J. Dadan, Z. Puchalski, and S. Sulkowski, “Assessment of proliferative activity of thyroid Hürthle cell tumors using PCNA, Ki-67 and AgNOR methods,” Folia Histochemica et Cytobiologica, vol. 42, no. 3, pp. 165–168, 2004.
[7]  M. H. Bukhari, S. Niazi, S. A. Khan et al., “Modified method of AgNOR staining for tissue and interpretation in histopathology,” International Journal of Experimental Pathology, vol. 88, no. 1, pp. 47–53, 2007.
[8]  B. M. Biswal and N. H. Othman, “Correlation of nuclear morphometry and AgNOR score with radiation response in squamous cell cancers of the head and neck: a preliminary study,” Malaysian Journal of Medical Sciences, vol. 17, no. 3, pp. 19–26, 2010.
[9]  S. Mukhopadhyay, “Quantitative estimation of AgNORs in inflammatory gingival overgrowth in pediatric patients and its correlation with the dental plaque status,” Journal of Indian Society of Pedodontics and Preventive Dentistry, vol. 27, no. 4, pp. 235–241, 2009.
[10]  G. F. Dumitrescu, “Diagnostic value of silver nitrate staining for nucleolar organizer regions in cerebral astrocytic tumors,” Romanian neurosurgery, vol. 17, no. 1, pp. 64–72, 2010.
[11]  L. D. C. Hildebrand, V. C. Carrard, I. D. S. Lauxen, O. F. De Quadros, A. C. M. Chaves, and M. Sant'Ana-Filho, “Evaluation of cell proliferation rate in non-dysplastic leukoplakias,” Medicina Oral, Patología Oral y Cirugía Bucal, vol. 15, no. 2, pp. e328–e334, 2010.
[12]  H. Ansari, G. Mehdi, V. Maheshwari, and S. Siddiqui, “Evaluation of AgNOR scores in aspiration cytology smears of breast tumors,” Journal of Cytology, vol. 25, no. 3, pp. 100–104, 2008.
[13]  W. A. Mourad, S. Devloo, and S. Setrakian, “Predictors of invasion in ductal carcinoma in situ of the breast: the value of a scoring system,” Annals of Saudi Medicine, vol. 17, no. 4, pp. 427–431, 1997.
[14]  A. Mehrotra, P. K. Agarwal, and T. Chandra, “Cytopathology and AgNOR counts in fine needle aspiration cytology smears of thyroid lesions,” Diagnostic Cytopathology, vol. 19, pp. 238–243, 1998.
[15]  M. H. Bukhari, S. Niazi, I. Hashmi et al., “Use of AgNOR index in grading and differential diagnosis of astrocytic lesions of brain,” Pakistan Journal of Medical Sciences, vol. 23, no. 2, pp. 206–210, 2007.
[16]  T. Elangovan, N. Mani, and N. Malathi, “Argyrophilic nucleolar organizer regions in inflammatory, premalignant, and malignant oral lesions: a quantitative and qualitative assessment,” Indian Journal of Dental Research, vol. 19, no. 2, pp. 141–146, 2008.
[17]  “Interphase nucleolar organizer regions in tumour pathology,” in Molecular Biology in Cellular Pathology, J. Crocker and P. G. Murray, Eds., pp. 144–145, John Wiley & Sons, London, UK, 2nd edition, 2003.
[18]  F. Lumachi, M. Ermani, F. Marino et al., “Relationship of AgNOR counts and nuclear DNA content to survival in patients with parathyroid carcinoma,” Endocrine-Related Cancer, vol. 11, no. 3, pp. 563–569, 2004.
[19]  A. H. Khan, S. A. Khan, N. A. Chaudhry, and M. Tayyab, “Comparison of argyrophilic nucleolar organizer regions (AgNORs) with proliferating cell nucleolar antigen (PCNA) in different grades of transitional cell carcinoma of urinary bladder,” Annals, vol. 13, no. 2, pp. 186–190, 2007.
[20]  H. Gharib and J. R. Goellner, “Fine-needle aspiration biopsy of the thyroid: an appraisal,” Annals of Internal Medicine, vol. 118, no. 4, pp. 282–289, 1993.
[21]  F. I. Wahid, S. F. Khan, H. U. Rehman, and I. A. Khan, “Role of fine needle aspiration cytology in diagnosis of solitary thyroid nodules,” Iranian Journal of Otorhinolaryngology, vol. 23, no. 4, pp. 111–118, 2011.
[22]  T. Solymosi, V. Toth, Z. Sapi, M. Bodo, I. Gal, and L. Csanadi, “Diagnostic value of AgNOR: method in thyroid cytopathology: correlation with morphometric measurements,” Diagnostic Cytopathology, vol. 14, no. 2, pp. 140–144, 1996.
[23]  D. Slowińska-Klencka, M. Klencki, B. Popowicz, S. Sporny, and A. Lewiński, “Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression,” Histology and Histopathology, vol. 19, no. 3, pp. 785–792, 2004.
[24]  H. B. Burch, K. D. Burman, H. L. Reed, L. Buckner, T. Raber, and J. L. Ownbey, “Fine needle aspiration of thyroid nodules: determinants of insufficiency rate and malignancy yield at thyroidectomy,” Acta Cytologica, vol. 40, no. 6, pp. 1176–1183, 1996.
[25]  N. Leonard and D. H. Melcher, “To operate or not to operate? The value of fine needle aspiration cytology in the assessment of thyroid swellings,” Journal of Clinical Pathology, vol. 50, no. 11, pp. 941–943, 1997.
[26]  T. W. Khanzada, A. Samad, B. Kumar, and W. Memon, “The diagnostic value of fine needle aspiration cytology in thyroid nodules,” Pakistan Journal of Otolaryngology, vol. 25, pp. 39–41, 2009.
[27]  J. B. Lingegowda, P. H. Muddegowda, R. N. Kumar, and R. R. Kurpad, “Application of pattern analysis in fine needle aspiration of solitary nodule of thyroid,” Journal of Cytology, vol. 27, no. 1, pp. 1–7, 2010.
[28]  J. H. Chern, Y. C. Lee, M. H. Yang, S. C. Chang, and R. P. Perng, “Usefulness of argyrophilic nucleolar organizer regions score to differentiate suspicious malignancy in pulmonary cytology,” Chest, vol. 111, no. 6, pp. 1591–1596, 1997.
[29]  Palaoro La, A. S. Rocher, J. Rofrano, S. M. Curi, and V. Penzutti, “Utility of AgNOR, Immunocytochemistry for CEA and tumour markers for diagnosis in serous fluids,” Revista Brasileria de Cancerologica, vol. 54, no. 4, pp. 317–327, 2008.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413